Chapter 1: The management of erectile dysfunction: an AUA update

J Urol. 2005 Jul;174(1):230-9. doi: 10.1097/01.ju.0000164463.19239.19.
No abstract available

Publication types

  • Guideline
  • Practice Guideline

MeSH terms

  • 3',5'-Cyclic-GMP Phosphodiesterases
  • Biomedical Research / trends
  • Cyclic Nucleotide Phosphodiesterases, Type 5
  • Erectile Dysfunction / complications
  • Erectile Dysfunction / diagnosis*
  • Erectile Dysfunction / therapy*
  • Forecasting
  • Humans
  • Male
  • Penile Prosthesis
  • Phosphodiesterase Inhibitors / therapeutic use
  • Phosphoric Diester Hydrolases
  • Vascular Surgical Procedures

Substances

  • Phosphodiesterase Inhibitors
  • Phosphoric Diester Hydrolases
  • 3',5'-Cyclic-GMP Phosphodiesterases
  • Cyclic Nucleotide Phosphodiesterases, Type 5
  • PDE5A protein, human